Immunodeficiency diseases caused by defects in phagocytes

New England Journal of Medicine

Volumn 343, Issue 23, 2000, Pages 1703-1714

  Lekstrom Himes, Julie A ^a   Gallin, John I ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MSC 1504 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; ENZYME DEFICIENCY; GRANULOMATOSIS; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY; NEUTROPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SHWACHMAN SYNDROME;

CELL ADHESION; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON TYPE II; NEUTROPENIA; PHAGOCYTES; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION;

EID: 0034619970     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012073432307     Document Type: Review

References (114)

1. Interferon-γ in the management of chronic granulomatous disease
2. Interferon-γ and interleukin-12 pathway defects and human disease
3. Primary inherited defects in neutrophil function: Etiology and treatment
4. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: Their quantitative definition and relation to leukocyte dysfunction and clinical features
5. Chronic neutropenia
6. Pathophysiology and treatment of severe chronic neutropenia
7. Severe chronic neutropenia: Pathophysiology and therapy
8. Diagnosis and management of chronic neutropenia during childhood
9. A fatal case of acute primary infectious pharyngitis with extreme leukopenia
10. Agranulocytosis: Report of a case
11. The neutropenic state: Its significance and therapeutic rationale
12. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis
13. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis
14. The proteinase-antiproteinase theory of emphysema: A speculative analysis of recent advances into the pathogenesis of emphysema
15. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors
16. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis
17. Cyclic neutropenia and other periodic hematological disorders: A review of mechanisms and mathematical models
18. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia
19. Severe congenital neutropenia terminating in acute myeloid leukemia: Disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene
20. Haematological abnormalities in Shwachman-Diamond syndrome
21. Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome
22. An inherited abnormality of neutrophil adhesion: Its genetic transmission and its association with a missing protein
23. Structure and function of leukocyte integrins
24. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies
25. A human leukocyte differentiation antigen family with distinct α-subunits and a common β-subunit: The lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule
26. Disorders of phagocyte function
27. Neutrophil adhesion and the therapy of inflammation
28. Leukocyte adherence-related glycoproteins LFA-1, Mo, and p150,95: A new group of monoclonal antibodies, a new disease, and a possible opportunity to understand the molecular basis of leukocyte adherence
29. Recurrent severe infections caused by a novel leukocyte adhesion deficiency
30. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2
31. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism
32. Inherited disorders of glycoprotein synthesis: Cell biological insights
33. Correction of leukocyte adhesion deficiency type II with oral fucose
34. Human neutrophil immuno-deficiency syndrome is associated with an inhibitory Rac2 mutation
35. Systemic infection following BCG therapy
36. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
37. Interferon-γ in the management of infectious diseases
38. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
39. The interplay between T helper subset cytokines and IL-12 in directing human B lymphocyte differentiation
40. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
41. Partial interferonγ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
42. A human IFNGR small deletion hotspot associated with dominant susceptibility to mycobacterial infection
43. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection
44. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
45. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
46. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
47. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
48. Hypergammaglobulinemia associated with severe recurrent and chronic nonspecific infection
49. A fatal granulomatosus of childhood: The clinical study of a new syndrome
50. In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood
51. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function
52. Leukocyte oxidase: Defective activity in chronicgranulomatous disease
53. Deficiency of reduced nicotinamideadenine dinucleotide oxidase in chronic granulomatous disease
54. Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood
55. Quantitative nitroblue tetrazolium test in chronic granulomatous disease
56. Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease
57. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors
58. Cytosolic components of the respiratory burst oxidase: Resolution of four components, two of which are missing in complementing types of chronic granulomatous disease
59. Genetic variants of chronic granulomatous disease: Prevalence of deficiencies of two cytosolic components of the NADPH oxidase system
60. Recombinant 47kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease
61. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src
62. The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245
63. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease
64. Cytochrome b558: The flavin-binding component of the phagocyte NADPH oxidase
65. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex
66. Cloning the gene for an inherited human disorder - Chronic granulomatous disease - On the basis of its chromosomal location
67. Human neutrophil cytochrome b light chain (p22-phox): Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease
68. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections
69. Chronic granulomatous disease: Report on a national registry of 368 patients
70. The urological manifestations of chronic granulomatous disease
71. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease
72. Flow cytometric analysis of the granulocyte respiratory burst: A comparison study of fluorescent probes
73. Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants
74. Clinical presentation and unusual infections in chronic granulomatous disease
75. Growth of Mycobacterium bovis, bacille Calmette-Guerin, within human monocytesmacrophages cultured in serum-free medium
76. Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease
77. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool
78. Severe phenotype of chronic granulomatous disease (CGD) presenting in a female with a spontaneous mutation in gp91phox and non-random X-chromosome inactivation
79. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease
80. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease
81. Bone marrow transplantation for chronic granulomatous disease: Long-term follow-up and review of literature
82. Nonmyeloblative, T-cell depleted allogeneic peripheral blood stem cell (PBSC) transplantation for patients with chronic granulomatous disease
83. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease
84. Insights into myeloperoxidase biosynthesis from its inherited deficiency
85. Myeloperoxidase-halide-hydrogen peroxide antibacterial system
86. Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction
87. Clinical manifestation of myeloperoxidase deficiency
88. Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan
89. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome
90. The Chediak-Higashi syndrome: Studies in four patients and a review of the literature
91. Nouvelle anomalie leucocytaire de caractere constitutionnel et familial
92. Congenital gigantism of peroxidase granules: The first case ever reported of qualitative abnormity of peroxidase
93. Chediak and Higashi's disease: Probable identity of 'a new leucocytal anomaly (Chediak)' and 'congenital gigantism of peroxidase granules (Higashi)'
94. The Chediak-Higashi syndrome: Studies of host defenses
95. The Chediak-Higashi syndrome: The nature of the giant neutrophil granules and their interactions with cytoplasm and foreign particulates. I. Progressive enlargement of the massive inclusions in mature neutrophils. II. Manifestations of cytoplasmic inquiry and sequestration. III. Interactions between giant organelles and foreign particulates
96. Immunocytochemical identification of azurophilic and specific granule markers in the giant granules of Chediak-Higashi syndrome neutrophils
97. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes
98. Identification of the homologous beige and Chediak-Higashi syndrome genes
99. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome
100. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome
101. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle
102. Microbicidal/ cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and 'specific' granule deficiency
103. Secretory responses of human neutrophils: Exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo
104. Neutrophil specific granule deficiency
105. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections: Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy
106. Abnormal neutrophil maturation in a neutrophil defect with morphologic abnormality and impaired function
107. Selective deficiency of granules associated with lysozyme and lactoferrin in human polymorphs with reduced microbicidal capacity
108. An anomaly of neutrophil morphology with impaired function
109. Neutrophil-specific granule deficiency includes eosinophils
110. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein
111. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice
112. CCAAT/enhancer binding protein is critical for effective neutrophil-mediated response to inflammatory challenge
113. Idem Biological role of the CCAAT/enhancer-binding protein family of transcription factors